19-9251062-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001079935.2(OR7E24):c.19C>A(p.Leu7Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000696 in 1,437,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001079935.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR7E24 | NM_001079935.2 | c.19C>A | p.Leu7Ile | missense_variant | 1/1 | ENST00000456448.3 | NP_001073404.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR7E24 | ENST00000456448.3 | c.19C>A | p.Leu7Ile | missense_variant | 1/1 | NM_001079935.2 | ENSP00000387523 | P2 | ||
OR7E24 | ENST00000641946.1 | c.30-23C>A | intron_variant | ENSP00000494223 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000464 AC: 1AN: 215612Hom.: 0 AF XY: 0.00000856 AC XY: 1AN XY: 116766
GnomAD4 exome AF: 6.96e-7 AC: 1AN: 1437784Hom.: 0 Cov.: 28 AF XY: 0.00000140 AC XY: 1AN XY: 713864
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2022 | The c.19C>A (p.L7I) alteration is located in exon 1 (coding exon 1) of the OR7E24 gene. This alteration results from a C to A substitution at nucleotide position 19, causing the leucine (L) at amino acid position 7 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at